Request for Covid-19 Impact Assessment of this Report
The United States Fluoxetine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Fluoxetine market, reaching US$ million by the year 2028. As for the Europe Fluoxetine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Fluoxetine players cover Teva, Sun Pharmaceutical, Sandoz, and Mylan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Fluoxetine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tablets
Capsules
Oral Solution
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Depression
Obsessive–Compulsive Disorder
Panic Disorder
Bulimia Nervosa
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Teva
Sun Pharmaceutical
Sandoz
Mylan
Wockhardt
Dr.Reddy's Laboratories
Pharmaceutical Associates Inc.
Lannett Company
Aurobindo Pharma
Alembic Pharmaceuticals
Alvogen
Torrent Pharmaceuticals
Suzhou YUSHI Pharmaceutical
Changzhou Siyao Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Fluoxetine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Fluoxetine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Fluoxetine by Country/Region, 2017, 2022 & 2028
2.2 Fluoxetine Segment by Type
2.2.1 Tablets
2.2.2 Capsules
2.2.3 Oral Solution
2.3 Fluoxetine Sales by Type
2.3.1 Global Fluoxetine Sales Market Share by Type (2017-2022)
2.3.2 Global Fluoxetine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Fluoxetine Sale Price by Type (2017-2022)
2.4 Fluoxetine Segment by Application
2.4.1 Depression
2.4.2 Obsessive–Compulsive Disorder
2.4.3 Panic Disorder
2.4.4 Bulimia Nervosa
2.4.5 Others
2.5 Fluoxetine Sales by Application
2.5.1 Global Fluoxetine Sale Market Share by Application (2017-2022)
2.5.2 Global Fluoxetine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Fluoxetine Sale Price by Application (2017-2022)
3 Global Fluoxetine by Company
3.1 Global Fluoxetine Breakdown Data by Company
3.1.1 Global Fluoxetine Annual Sales by Company (2020-2022)
3.1.2 Global Fluoxetine Sales Market Share by Company (2020-2022)
3.2 Global Fluoxetine Annual Revenue by Company (2020-2022)
3.2.1 Global Fluoxetine Revenue by Company (2020-2022)
3.2.2 Global Fluoxetine Revenue Market Share by Company (2020-2022)
3.3 Global Fluoxetine Sale Price by Company
3.4 Key Manufacturers Fluoxetine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fluoxetine Product Location Distribution
3.4.2 Players Fluoxetine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Fluoxetine by Geographic Region
4.1 World Historic Fluoxetine Market Size by Geographic Region (2017-2022)
4.1.1 Global Fluoxetine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Fluoxetine Annual Revenue by Geographic Region
4.2 World Historic Fluoxetine Market Size by Country/Region (2017-2022)
4.2.1 Global Fluoxetine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Fluoxetine Annual Revenue by Country/Region
4.3 Americas Fluoxetine Sales Growth
4.4 APAC Fluoxetine Sales Growth
4.5 Europe Fluoxetine Sales Growth
4.6 Middle East & Africa Fluoxetine Sales Growth
5 Americas
5.1 Americas Fluoxetine Sales by Country
5.1.1 Americas Fluoxetine Sales by Country (2017-2022)
5.1.2 Americas Fluoxetine Revenue by Country (2017-2022)
5.2 Americas Fluoxetine Sales by Type
5.3 Americas Fluoxetine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fluoxetine Sales by Region
6.1.1 APAC Fluoxetine Sales by Region (2017-2022)
6.1.2 APAC Fluoxetine Revenue by Region (2017-2022)
6.2 APAC Fluoxetine Sales by Type
6.3 APAC Fluoxetine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Fluoxetine by Country
7.1.1 Europe Fluoxetine Sales by Country (2017-2022)
7.1.2 Europe Fluoxetine Revenue by Country (2017-2022)
7.2 Europe Fluoxetine Sales by Type
7.3 Europe Fluoxetine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Fluoxetine by Country
8.1.1 Middle East & Africa Fluoxetine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Fluoxetine Revenue by Country (2017-2022)
8.2 Middle East & Africa Fluoxetine Sales by Type
8.3 Middle East & Africa Fluoxetine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fluoxetine
10.3 Manufacturing Process Analysis of Fluoxetine
10.4 Industry Chain Structure of Fluoxetine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fluoxetine Distributors
11.3 Fluoxetine Customer
12 World Forecast Review for Fluoxetine by Geographic Region
12.1 Global Fluoxetine Market Size Forecast by Region
12.1.1 Global Fluoxetine Forecast by Region (2023-2028)
12.1.2 Global Fluoxetine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Fluoxetine Forecast by Type
12.7 Global Fluoxetine Forecast by Application
13 Key Players Analysis
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Fluoxetine Product Offered
13.1.3 Teva Fluoxetine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Sun Pharmaceutical
13.2.1 Sun Pharmaceutical Company Information
13.2.2 Sun Pharmaceutical Fluoxetine Product Offered
13.2.3 Sun Pharmaceutical Fluoxetine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sun Pharmaceutical Main Business Overview
13.2.5 Sun Pharmaceutical Latest Developments
13.3 Sandoz
13.3.1 Sandoz Company Information
13.3.2 Sandoz Fluoxetine Product Offered
13.3.3 Sandoz Fluoxetine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sandoz Main Business Overview
13.3.5 Sandoz Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Fluoxetine Product Offered
13.4.3 Mylan Fluoxetine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Wockhardt
13.5.1 Wockhardt Company Information
13.5.2 Wockhardt Fluoxetine Product Offered
13.5.3 Wockhardt Fluoxetine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Wockhardt Main Business Overview
13.5.5 Wockhardt Latest Developments
13.6 Dr.Reddy's Laboratories
13.6.1 Dr.Reddy's Laboratories Company Information
13.6.2 Dr.Reddy's Laboratories Fluoxetine Product Offered
13.6.3 Dr.Reddy's Laboratories Fluoxetine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Dr.Reddy's Laboratories Main Business Overview
13.6.5 Dr.Reddy's Laboratories Latest Developments
13.7 Pharmaceutical Associates Inc.
13.7.1 Pharmaceutical Associates Inc. Company Information
13.7.2 Pharmaceutical Associates Inc. Fluoxetine Product Offered
13.7.3 Pharmaceutical Associates Inc. Fluoxetine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Pharmaceutical Associates Inc. Main Business Overview
13.7.5 Pharmaceutical Associates Inc. Latest Developments
13.8 Lannett Company
13.8.1 Lannett Company Company Information
13.8.2 Lannett Company Fluoxetine Product Offered
13.8.3 Lannett Company Fluoxetine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Lannett Company Main Business Overview
13.8.5 Lannett Company Latest Developments
13.9 Aurobindo Pharma
13.9.1 Aurobindo Pharma Company Information
13.9.2 Aurobindo Pharma Fluoxetine Product Offered
13.9.3 Aurobindo Pharma Fluoxetine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Aurobindo Pharma Main Business Overview
13.9.5 Aurobindo Pharma Latest Developments
13.10 Alembic Pharmaceuticals
13.10.1 Alembic Pharmaceuticals Company Information
13.10.2 Alembic Pharmaceuticals Fluoxetine Product Offered
13.10.3 Alembic Pharmaceuticals Fluoxetine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Alembic Pharmaceuticals Main Business Overview
13.10.5 Alembic Pharmaceuticals Latest Developments
13.11 Alvogen
13.11.1 Alvogen Company Information
13.11.2 Alvogen Fluoxetine Product Offered
13.11.3 Alvogen Fluoxetine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Alvogen Main Business Overview
13.11.5 Alvogen Latest Developments
13.12 Torrent Pharmaceuticals
13.12.1 Torrent Pharmaceuticals Company Information
13.12.2 Torrent Pharmaceuticals Fluoxetine Product Offered
13.12.3 Torrent Pharmaceuticals Fluoxetine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Torrent Pharmaceuticals Main Business Overview
13.12.5 Torrent Pharmaceuticals Latest Developments
13.13 Suzhou YUSHI Pharmaceutical
13.13.1 Suzhou YUSHI Pharmaceutical Company Information
13.13.2 Suzhou YUSHI Pharmaceutical Fluoxetine Product Offered
13.13.3 Suzhou YUSHI Pharmaceutical Fluoxetine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Suzhou YUSHI Pharmaceutical Main Business Overview
13.13.5 Suzhou YUSHI Pharmaceutical Latest Developments
13.14 Changzhou Siyao Pharmaceutical
13.14.1 Changzhou Siyao Pharmaceutical Company Information
13.14.2 Changzhou Siyao Pharmaceutical Fluoxetine Product Offered
13.14.3 Changzhou Siyao Pharmaceutical Fluoxetine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Changzhou Siyao Pharmaceutical Main Business Overview
13.14.5 Changzhou Siyao Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Fluoxetine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Fluoxetine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Capsules
Table 5. Major Players of Oral Solution
Table 6. Global Fluoxetine Sales by Type (2017-2022) & (K Units)
Table 7. Global Fluoxetine Sales Market Share by Type (2017-2022)
Table 8. Global Fluoxetine Revenue by Type (2017-2022) & ($ million)
Table 9. Global Fluoxetine Revenue Market Share by Type (2017-2022)
Table 10. Global Fluoxetine Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Fluoxetine Sales by Application (2017-2022) & (K Units)
Table 12. Global Fluoxetine Sales Market Share by Application (2017-2022)
Table 13. Global Fluoxetine Revenue by Application (2017-2022)
Table 14. Global Fluoxetine Revenue Market Share by Application (2017-2022)
Table 15. Global Fluoxetine Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Fluoxetine Sales by Company (2020-2022) & (K Units)
Table 17. Global Fluoxetine Sales Market Share by Company (2020-2022)
Table 18. Global Fluoxetine Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Fluoxetine Revenue Market Share by Company (2020-2022)
Table 20. Global Fluoxetine Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Fluoxetine Producing Area Distribution and Sales Area
Table 22. Players Fluoxetine Products Offered
Table 23. Fluoxetine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Fluoxetine Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Fluoxetine Sales Market Share Geographic Region (2017-2022)
Table 28. Global Fluoxetine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Fluoxetine Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Fluoxetine Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Fluoxetine Sales Market Share by Country/Region (2017-2022)
Table 32. Global Fluoxetine Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Fluoxetine Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Fluoxetine Sales by Country (2017-2022) & (K Units)
Table 35. Americas Fluoxetine Sales Market Share by Country (2017-2022)
Table 36. Americas Fluoxetine Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Fluoxetine Revenue Market Share by Country (2017-2022)
Table 38. Americas Fluoxetine Sales by Type (2017-2022) & (K Units)
Table 39. Americas Fluoxetine Sales Market Share by Type (2017-2022)
Table 40. Americas Fluoxetine Sales by Application (2017-2022) & (K Units)
Table 41. Americas Fluoxetine Sales Market Share by Application (2017-2022)
Table 42. APAC Fluoxetine Sales by Region (2017-2022) & (K Units)
Table 43. APAC Fluoxetine Sales Market Share by Region (2017-2022)
Table 44. APAC Fluoxetine Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Fluoxetine Revenue Market Share by Region (2017-2022)
Table 46. APAC Fluoxetine Sales by Type (2017-2022) & (K Units)
Table 47. APAC Fluoxetine Sales Market Share by Type (2017-2022)
Table 48. APAC Fluoxetine Sales by Application (2017-2022) & (K Units)
Table 49. APAC Fluoxetine Sales Market Share by Application (2017-2022)
Table 50. Europe Fluoxetine Sales by Country (2017-2022) & (K Units)
Table 51. Europe Fluoxetine Sales Market Share by Country (2017-2022)
Table 52. Europe Fluoxetine Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Fluoxetine Revenue Market Share by Country (2017-2022)
Table 54. Europe Fluoxetine Sales by Type (2017-2022) & (K Units)
Table 55. Europe Fluoxetine Sales Market Share by Type (2017-2022)
Table 56. Europe Fluoxetine Sales by Application (2017-2022) & (K Units)
Table 57. Europe Fluoxetine Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Fluoxetine Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Fluoxetine Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Fluoxetine Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Fluoxetine Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Fluoxetine Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Fluoxetine Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Fluoxetine Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Fluoxetine Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Fluoxetine
Table 67. Key Market Challenges & Risks of Fluoxetine
Table 68. Key Industry Trends of Fluoxetine
Table 69. Fluoxetine Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Fluoxetine Distributors List
Table 72. Fluoxetine Customer List
Table 73. Global Fluoxetine Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Fluoxetine Sales Market Forecast by Region
Table 75. Global Fluoxetine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Fluoxetine Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Fluoxetine Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Fluoxetine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Fluoxetine Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Fluoxetine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Fluoxetine Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Fluoxetine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Fluoxetine Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Fluoxetine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Fluoxetine Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Fluoxetine Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Fluoxetine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Fluoxetine Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Fluoxetine Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Fluoxetine Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Fluoxetine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Fluoxetine Revenue Market Share Forecast by Application (2023-2028)
Table 93. Teva Basic Information, Fluoxetine Manufacturing Base, Sales Area and Its Competitors
Table 94. Teva Fluoxetine Product Offered
Table 95. Teva Fluoxetine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Teva Main Business
Table 97. Teva Latest Developments
Table 98. Sun Pharmaceutical Basic Information, Fluoxetine Manufacturing Base, Sales Area and Its Competitors
Table 99. Sun Pharmaceutical Fluoxetine Product Offered
Table 100. Sun Pharmaceutical Fluoxetine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. Sun Pharmaceutical Main Business
Table 102. Sun Pharmaceutical Latest Developments
Table 103. Sandoz Basic Information, Fluoxetine Manufacturing Base, Sales Area and Its Competitors
Table 104. Sandoz Fluoxetine Product Offered
Table 105. Sandoz Fluoxetine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. Sandoz Main Business
Table 107. Sandoz Latest Developments
Table 108. Mylan Basic Information, Fluoxetine Manufacturing Base, Sales Area and Its Competitors
Table 109. Mylan Fluoxetine Product Offered
Table 110. Mylan Fluoxetine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. Mylan Main Business
Table 112. Mylan Latest Developments
Table 113. Wockhardt Basic Information, Fluoxetine Manufacturing Base, Sales Area and Its Competitors
Table 114. Wockhardt Fluoxetine Product Offered
Table 115. Wockhardt Fluoxetine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. Wockhardt Main Business
Table 117. Wockhardt Latest Developments
Table 118. Dr.Reddy's Laboratories Basic Information, Fluoxetine Manufacturing Base, Sales Area and Its Competitors
Table 119. Dr.Reddy's Laboratories Fluoxetine Product Offered
Table 120. Dr.Reddy's Laboratories Fluoxetine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. Dr.Reddy's Laboratories Main Business
Table 122. Dr.Reddy's Laboratories Latest Developments
Table 123. Pharmaceutical Associates Inc. Basic Information, Fluoxetine Manufacturing Base, Sales Area and Its Competitors
Table 124. Pharmaceutical Associates Inc. Fluoxetine Product Offered
Table 125. Pharmaceutical Associates Inc. Fluoxetine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. Pharmaceutical Associates Inc. Main Business
Table 127. Pharmaceutical Associates Inc. Latest Developments
Table 128. Lannett Company Basic Information, Fluoxetine Manufacturing Base, Sales Area and Its Competitors
Table 129. Lannett Company Fluoxetine Product Offered
Table 130. Lannett Company Fluoxetine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 131. Lannett Company Main Business
Table 132. Lannett Company Latest Developments
Table 133. Aurobindo Pharma Basic Information, Fluoxetine Manufacturing Base, Sales Area and Its Competitors
Table 134. Aurobindo Pharma Fluoxetine Product Offered
Table 135. Aurobindo Pharma Fluoxetine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 136. Aurobindo Pharma Main Business
Table 137. Aurobindo Pharma Latest Developments
Table 138. Alembic Pharmaceuticals Basic Information, Fluoxetine Manufacturing Base, Sales Area and Its Competitors
Table 139. Alembic Pharmaceuticals Fluoxetine Product Offered
Table 140. Alembic Pharmaceuticals Fluoxetine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 141. Alembic Pharmaceuticals Main Business
Table 142. Alembic Pharmaceuticals Latest Developments
Table 143. Alvogen Basic Information, Fluoxetine Manufacturing Base, Sales Area and Its Competitors
Table 144. Alvogen Fluoxetine Product Offered
Table 145. Alvogen Fluoxetine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 146. Alvogen Main Business
Table 147. Alvogen Latest Developments
Table 148. Torrent Pharmaceuticals Basic Information, Fluoxetine Manufacturing Base, Sales Area and Its Competitors
Table 149. Torrent Pharmaceuticals Fluoxetine Product Offered
Table 150. Torrent Pharmaceuticals Fluoxetine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 151. Torrent Pharmaceuticals Main Business
Table 152. Torrent Pharmaceuticals Latest Developments
Table 153. Suzhou YUSHI Pharmaceutical Basic Information, Fluoxetine Manufacturing Base, Sales Area and Its Competitors
Table 154. Suzhou YUSHI Pharmaceutical Fluoxetine Product Offered
Table 155. Suzhou YUSHI Pharmaceutical Fluoxetine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 156. Suzhou YUSHI Pharmaceutical Main Business
Table 157. Suzhou YUSHI Pharmaceutical Latest Developments
Table 158. Changzhou Siyao Pharmaceutical Basic Information, Fluoxetine Manufacturing Base, Sales Area and Its Competitors
Table 159. Changzhou Siyao Pharmaceutical Fluoxetine Product Offered
Table 160. Changzhou Siyao Pharmaceutical Fluoxetine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 161. Changzhou Siyao Pharmaceutical Main Business
Table 162. Changzhou Siyao Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Fluoxetine
Figure 2. Fluoxetine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Fluoxetine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Fluoxetine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Fluoxetine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Capsules
Figure 11. Product Picture of Oral Solution
Figure 12. Global Fluoxetine Sales Market Share by Type in 2021
Figure 13. Global Fluoxetine Revenue Market Share by Type (2017-2022)
Figure 14. Fluoxetine Consumed in Depression
Figure 15. Global Fluoxetine Market: Depression (2017-2022) & (K Units)
Figure 16. Fluoxetine Consumed in Obsessive–Compulsive Disorder
Figure 17. Global Fluoxetine Market: Obsessive–Compulsive Disorder (2017-2022) & (K Units)
Figure 18. Fluoxetine Consumed in Panic Disorder
Figure 19. Global Fluoxetine Market: Panic Disorder (2017-2022) & (K Units)
Figure 20. Fluoxetine Consumed in Bulimia Nervosa
Figure 21. Global Fluoxetine Market: Bulimia Nervosa (2017-2022) & (K Units)
Figure 22. Fluoxetine Consumed in Others
Figure 23. Global Fluoxetine Market: Others (2017-2022) & (K Units)
Figure 24. Global Fluoxetine Sales Market Share by Application (2017-2022)
Figure 25. Global Fluoxetine Revenue Market Share by Application in 2021
Figure 26. Fluoxetine Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Fluoxetine Revenue Market Share by Company in 2021
Figure 28. Global Fluoxetine Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Fluoxetine Revenue Market Share by Geographic Region in 2021
Figure 30. Global Fluoxetine Sales Market Share by Region (2017-2022)
Figure 31. Global Fluoxetine Revenue Market Share by Country/Region in 2021
Figure 32. Americas Fluoxetine Sales 2017-2022 (K Units)
Figure 33. Americas Fluoxetine Revenue 2017-2022 ($ Millions)
Figure 34. APAC Fluoxetine Sales 2017-2022 (K Units)
Figure 35. APAC Fluoxetine Revenue 2017-2022 ($ Millions)
Figure 36. Europe Fluoxetine Sales 2017-2022 (K Units)
Figure 37. Europe Fluoxetine Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Fluoxetine Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Fluoxetine Revenue 2017-2022 ($ Millions)
Figure 40. Americas Fluoxetine Sales Market Share by Country in 2021
Figure 41. Americas Fluoxetine Revenue Market Share by Country in 2021
Figure 42. United States Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Fluoxetine Sales Market Share by Region in 2021
Figure 47. APAC Fluoxetine Revenue Market Share by Regions in 2021
Figure 48. China Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Fluoxetine Sales Market Share by Country in 2021
Figure 55. Europe Fluoxetine Revenue Market Share by Country in 2021
Figure 56. Germany Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Fluoxetine Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Fluoxetine Revenue Market Share by Country in 2021
Figure 63. Egypt Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Fluoxetine Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Fluoxetine in 2021
Figure 69. Manufacturing Process Analysis of Fluoxetine
Figure 70. Industry Chain Structure of Fluoxetine
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...